Syprine 250 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FAAGN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,486
Award facts
- Contract value 100% obligated
- $14,486.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,486.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Syprine 250 mg, a pharmaceutical product used in the treatment of Wilson's disease. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of July 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion prime vendor agreement valued through December 2026.
As a major pharmaceutical distributor serving federal military and veteran healthcare systems, AmerisourceBergen Drug Corp maintains an extensive portfolio of medical product deliveries with the Defense Logistics Agency. The company's federal contracting history demonstrates consistent competitively awarded delivery orders with firm fixed pricing across a broad spectrum of pharmaceutical and medical supply categories. This particular delivery order for Syprine contributes to the company's ongoing support of military healthcare programs and the Defense Health Agency's pharmaceutical supply chain requirements. The non-set-aside competitive award reflects AmerisourceBergen's demonstrated capability to meet federal procurement standards and its role as a critical vendor within DLA's medical supply infrastructure.
Quick answers
Who was awarded contract SPE2DB25FAAGN?
SPE2DB25FAAGN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 10, 2025.
How much is contract SPE2DB25FAAGN worth?
The government has obligated $14,486 on SPE2DB25FAAGN.
Is contract SPE2DB25FAAGN an order under another contract?
Yes. SPE2DB25FAAGN is a delivery order under SPE2DB24D2010, an indefinite delivery contract.
Was contract SPE2DB25FAAGN competed?
The extent of competition for SPE2DB25FAAGN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award